Syntax Research »

Lexicon Pharmaceuticals shares owned by Syntax Research

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Syntax Research from 13F filings

Historical chart of Syntax Research investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Syntax Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Syntax Research

Quarter filed Position value Share count Share price at filing
2023-12-31 $217 142 1.54

More positions owned by Syntax Research

Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Usa Value (VLUE)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Acwi Ex Us (ACWX)
Proshares Tr S&p 500 Dv Arist (NOBL)
Ishares Tr Core Msci Euro (IEUR)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Qualcomm (QCOM)
Microsoft Corporation (MSFT)
FedEx Corporation (FDX)
American Tower Reit (AMT)
Prologis (PLD)

View all positions for Syntax Research

Top funds holding Lexicon Pharmaceuticals

Artal Group
BVF
Vanguard Group
Jpmorgan Chase & Co
NEA Management Company
Gail Mannix
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
GSA Capital Partners
D. E. Shaw & Co
Bank of New York Mellon
Connor, Clark & Lunn Investment Management
Jane Street
Virtus ETF Advisers

View all funds holding Lexicon Pharmaceuticals